Senior Manager, Stewardship Operations, Quality & Evidence
Regeneron Pharmaceuticals
Summary
The Senior Manager, Stewardship Operations, Quality & Evidence is responsible for the continuous data-quality monitoring capability for enterprise planning data, turning ratified standards and business rules into active checks, routed flags, and decision-ready evidence. This role owns the monitoring, escalation-routing, and reporting cadence that keeps data quality issues visible before they reach a finished report, and compiles the evidence base the Data Stewardship Council and senior leadership use to review conformance and prioritize future stewardship work.
Job description
Discover your role
- Operate and continuously improve enterprise data-quality monitoring in Planisware (leveraging the Data Quality Audit capability), configuring checks to reflect currently ratified definitions, business rules, and RACI assignments.
- Monitor planning data continuously against core data-quality dimensions – completeness, accuracy, consistency, uniqueness, validity, and timeliness – and route flagged issues directly to the accountable plan owner for resolution at the source.
- Compile and maintain the monthly data-quality summary presented to the Data Stewardship Council, highlighting recurring issues, trends by function, and items requiring escalation.
- Produce the quarterly data-quality trend report for senior leadership, providing the evidence base used to prioritize future stewardship and quality initiatives.
- Maintain a system of record (audit trail) documenting monitoring results, flagged issues, remediation status, and outcomes, to support auditability and knowledge continuity across review cycles.
- Partner with Digital & Technology to keep monitoring tooling configured to current ratified standards, distinguishing tooling or system defects from underlying data-content issues and routing each to the correct owner.
- Track and report adoption and conformance by role – Data Creator, Curator, Enabler, and Consumer – to identify where an agreed expectation is not being met and where follow-up is needed.
- Support the Sr. Manager, Enterprise Stewardship & Standards, and the Director, Data Stewardship, in assembling monitoring evidence for decision records and escalation packages when a flagged finding surfaces a cross-functional disagreement requiring Council resolution.
- Track and report on monitoring coverage (e.g., share of required or active milestone codes under active monitoring) and issue closure rates, providing input to the broader stewardship roadmap and operating-model maturity.
- Collaborate with system Business Process Owner (e.g., Planisware, Planview) and Program, Portfolio Management, and Program Management leads to ensure monitoring reflects current planning-system configuration and usage.
This role requires
- Working knowledge of drug development, clinical/program planning, and portfolio management terminology and processes.
- Demonstrated experience operating or administering data-quality monitoring, audit, or observability capabilities (e.g., automated data-quality checks, exception and alert routing, conformance dashboards), ideally within a data governance or data management framework.
- Skilled in defining and tracking data-quality metrics against recognized dimensions (e.g., completeness, accuracy, consistency, uniqueness, validity, timeliness) and translating monitoring output into clear findings.
- Strong evidence-based reporting skills, with a proven ability to compile monitoring results into decision-ready summaries for audiences ranging from function leads to senior leadership.
- Excellent written communication skills, including the ability to produce clear, concise operational and trend reporting for governance and leadership review.
- Familiarity with Planisware (or comparable project/portfolio planning systems) and its data-quality and reporting capabilities; ability to partner effectively with technical teams on tooling configuration without owning the underlying build.
- Strong analytical and problem-solving skills, comfortable working with large operational datasets to identify patterns and root causes.
- Ability to work independently and collaboratively in a matrixed organization, partnering with Data Governance, Data Analytics & Data Science (DA&DS), Digital & Technology, and domain data stewards.
Preferred Qualifications
- Experience with data observability or data-quality tooling (e.g., Monte Carlo, Collibra, Informatica) is a plus.
- Data management or governance certification (e.g., CDMP) and/or PMI Project Management Professional (PMP) is preferred, but not required.
Education & Experience
- Bachelor's Degree required.
- 8+ years in data management, data quality/observability operations, business analysis, or related roles, including experience operating monitoring or reporting capabilities and producing evidence for governance bodies.
- Biopharma / drug development experience preferred.
Requirements
- Working knowledge of drug development, clinical/program planning, and portfolio management terminology and processes
- Demonstrated experience operating or administering data-quality monitoring, audit, or observability capabilities
- Skilled in defining and tracking data-quality metrics against recognized dimensions
- Strong evidence-based reporting skills
- Excellent written communication skills
- Familiarity with Planisware or comparable project/portfolio planning systems
- Strong analytical and problem-solving skills
- Ability to work independently and collaboratively in a matrixed organization
- Bachelor's Degree required
- 8+ years in data management, data quality/observability operations, business analysis, or related roles
Benefits
- Annual Bonuses
- Incentive Plans
- Equity Awards
- Pension or Retirement Benefits
- 401(k) Company Match
- Health and Wellness Programs
- Fitness Centers
- Medical, Dental & Vision
- Life & Disability Insurance
- Paid Time Off
- Family Support Benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.